Research ArticleDrug Discovery and Translational Medicine
DS-8500a, an Orally Available G Protein-Coupled Receptor 119 Agonist, Upregulates Glucagon-Like Peptide-1 and Enhances Glucose-Dependent Insulin Secretion and Improves Glucose Homeostasis in Type 2 Diabetic Rats
Koji Matsumoto, Tomomi Yoshitomi, Yoko Ishimoto, Naomi Tanaka, Kanako Takahashi, Akiko Watanabe and Katsuyoshi Chiba
Journal of Pharmacology and Experimental Therapeutics December 2018, 367 (3) 509-517; DOI: https://doi.org/10.1124/jpet.118.250019
Koji Matsumoto
End-Organ Disease Laboratories (K.M., T.Y., Y.I., N.T., K.T.), Drug Metabolism and Pharmacokinetics Research Laboratories (A.W.), and Medicinal Safety Research Laboratories (K.C.), Daiichi Sankyo Company Limited, Tokyo, Japan
Tomomi Yoshitomi
End-Organ Disease Laboratories (K.M., T.Y., Y.I., N.T., K.T.), Drug Metabolism and Pharmacokinetics Research Laboratories (A.W.), and Medicinal Safety Research Laboratories (K.C.), Daiichi Sankyo Company Limited, Tokyo, Japan
Yoko Ishimoto
End-Organ Disease Laboratories (K.M., T.Y., Y.I., N.T., K.T.), Drug Metabolism and Pharmacokinetics Research Laboratories (A.W.), and Medicinal Safety Research Laboratories (K.C.), Daiichi Sankyo Company Limited, Tokyo, Japan
Naomi Tanaka
End-Organ Disease Laboratories (K.M., T.Y., Y.I., N.T., K.T.), Drug Metabolism and Pharmacokinetics Research Laboratories (A.W.), and Medicinal Safety Research Laboratories (K.C.), Daiichi Sankyo Company Limited, Tokyo, Japan
Kanako Takahashi
End-Organ Disease Laboratories (K.M., T.Y., Y.I., N.T., K.T.), Drug Metabolism and Pharmacokinetics Research Laboratories (A.W.), and Medicinal Safety Research Laboratories (K.C.), Daiichi Sankyo Company Limited, Tokyo, Japan
Akiko Watanabe
End-Organ Disease Laboratories (K.M., T.Y., Y.I., N.T., K.T.), Drug Metabolism and Pharmacokinetics Research Laboratories (A.W.), and Medicinal Safety Research Laboratories (K.C.), Daiichi Sankyo Company Limited, Tokyo, Japan
Katsuyoshi Chiba
End-Organ Disease Laboratories (K.M., T.Y., Y.I., N.T., K.T.), Drug Metabolism and Pharmacokinetics Research Laboratories (A.W.), and Medicinal Safety Research Laboratories (K.C.), Daiichi Sankyo Company Limited, Tokyo, Japan
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleDrug Discovery and Translational Medicine
DS-8500a, a Novel GPR119 Agonist
Koji Matsumoto, Tomomi Yoshitomi, Yoko Ishimoto, Naomi Tanaka, Kanako Takahashi, Akiko Watanabe and Katsuyoshi Chiba
Journal of Pharmacology and Experimental Therapeutics December 1, 2018, 367 (3) 509-517; DOI: https://doi.org/10.1124/jpet.118.250019
Research ArticleDrug Discovery and Translational Medicine
DS-8500a, a Novel GPR119 Agonist
Koji Matsumoto, Tomomi Yoshitomi, Yoko Ishimoto, Naomi Tanaka, Kanako Takahashi, Akiko Watanabe and Katsuyoshi Chiba
Journal of Pharmacology and Experimental Therapeutics December 1, 2018, 367 (3) 509-517; DOI: https://doi.org/10.1124/jpet.118.250019
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement